Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 26 for your search:
Start Over
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EA1/174/05, NCT00168987
Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 123omega, VN2005/35, NCT00488904
Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NKP_CA_04, NCT01596933
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069218, NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, SC18, NCT00031707
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: S0927, U10CA037429, SWOG-S0927, NCT01385137
Vitamin D and Omega-3 Trial (VITAL)
Phase: Phase III
Type: Prevention
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2009P-001217, NCT01169259
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065766, CLB-9473, NCI-P97-0097, CALGB-9473, NCT00003077
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: P50 AT000437, JHM - IRB # 03-02-10-12, NCT00094562
Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies
Phase: Phase II
Type: Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007DR2232, 1345 (institution), 120/07 (ethics review board), NCT00533078
The Effect of Fish Oils on Human Hepatic Colorectal Metastases
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 10097, REC reference: 06/Q2501/160, EudraCT number: 2006-000044-71, NCT00942292
A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09/H0408/51, EudraCT number 2009-009470027, UHL trial number 10720, NCT01019382
Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10024, NCI-2012-02933, NCT01282580
Dietary Intervention Study of Low-Fat Diet, Fish Oil, and Soy Supplements in Breast Cancer Patients
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCLA-HSPC-9508339, NCI-V96-0940
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000443617, P30CA069533, OHSU-CI-CPC-04131-LX, VAMC-04-0303/ M1016, DOD-W81XWH-04-1-0296, OHSU-1117, KPNW-NW-05SLIEB-01, VAMC-04-0303, DOD-A-12538, OHSU-KPNW-NW-05SLIEB-01, NCT00253643
FishGastro Study: Fish Consumption and Gastro-Intestinal Health
Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: IFR02/2004, NCT00145015
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000505501, UCSF-03553, UCSF-H5664-22834-04A, NCT00402285
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 21
Sponsor: NCI, Other
Protocol IDs: CDR0000581419, P30CA069533, OHSU-3872, OHSU-CTRC-1037, NCI-2013-00768, 3872, NCT00627276
Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 35 to 70
Sponsor: Other
Protocol IDs: 26970, NCT00723398
Low-Fat Fish Oil Diet for Prostate Cancer Prevention
Phase: No phase specified
Type: Behavioral study, Biomarker/Laboratory analysis
Status: Closed
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 01-07-026, P50 CA 92131-01A1, NCT00798876
An Immunonutritional Approach to the Prevention of Skin Cancer
Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AICR 08-0131, UKCRN 6873, NCT01032343
A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 70
Sponsor: Other
Protocol IDs: PHO-0702, NCT01127867
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-11022, NCI-2011-03262, NCT01478477
Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 20.179/2010-0, NCT01575340
Start Over